Laboratory assessment of trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism.
Carolina ArenasDolores Pérez AlenzaPaula García San JoséLidia LlauetLaura Pérez-LópezCarlos MeliánEdward C FeldmanPublished in: Journal of veterinary internal medicine (2020)
No single variable or group of variables reliably discriminated A dogs from U dogs during trilostane treatment for PDH.
Keyphrases